Leucovorin: A Promising New Therapy Now Offered at Reign-Bow Brain Treatment Center
A New Addition to Our Evidence-Based Autism Treatment OptionsAt Reign-Bow Brain Treatment Center, our mission has always been to provide the most personalized, science-driven, and compassionate care for individuals on…
A New Addition to Our Evidence-Based Autism Treatment Options
At Reign-Bow Brain Treatment Center, our mission has always been to provide the most personalized, science-driven, and compassionate care for individuals on the autism spectrum. Today, we are excited to announce the addition of Leucovorin (folinic acid) therapy as an optional treatment for qualified patients.
Leucovorin has gained significant attention in recent years for its potential benefits in children and adults with autism—especially those with specific metabolic or genetic markers affecting folate pathways. While research is still evolving, early studies and clinical observations show meaningful improvements for some patients in areas such as communication, language development, attention, and social engagement.
Our team, guided by qEEG brain mapping, clinical assessments, and collaborative medical review, will now be able to offer this targeted therapy where appropriate.
What Is Leucovorin?
Leucovorin (also called folinic acid) is an activated form of folate—far more bioavailable than traditional folic acid.
For individuals with Folate Receptor Alpha Autoantibodies (FRAA) or Cerebral Folate Deficiency, the brain may struggle to transport or use folate effectively.
Why does this matter?
Folate is essential for:
Healthy brain development
Neurotransmitter production
Mitochondrial function
DNA repair
Cognitive and language processing
When the brain cannot access folate properly, neurological symptoms—including some seen in autism—can become more pronounced.
Leucovorin bypasses this problem by providing the activated form of folate the brain can use immediately and efficiently.
What Does the Research Say?
While Leucovorin is not FDA-approved specifically for autism, several peer-reviewed studies have found promising results:
✔ Improvements in verbal communication
In a randomized controlled trial published in Molecular Psychiatry, children receiving Leucovorin showed significant gains in expressive and receptive language compared to placebo.
✔ Better social functioning and attention
Clinical observation has shown improved eye contact, reduced irritability, and stronger engagement in some patients.
✔ Positive effects in children with FRAA
Up to 60–70% of children with ASD test positive for Folate Receptor Alpha Autoantibodies.
These children appear to respond particularly well to folinic acid therapy.
✔ Supports mitochondrial function
Because many autistic individuals also experience mitochondrial inefficiencies, Leucovorin may help support energy production and cellular health.
How We Use Leucovorin at Reign-Bow
We believe in precision-guided treatment, not one-size-fits-all medicine.
Your Leucovorin treatment plan may include:
1. Medical Evaluation
A thorough review with our medical team—including history, symptoms, and (if indicated) folate-related labs.
2. qEEG Brain Mapping Correlation
We evaluate how brainwave patterns and connectivity might relate to metabolic function, attention, language, and cognitive load.
3. Individualized Dosing Protocol
Dosing is based on current research, age, weight, and clinical presentation.
We start low, monitor closely, and adjust based on response.
4. Ongoing Clinical Monitoring
Our NP and medical director track progress in:
Speech and communication
Emotional regulation
Sleep patterns
Behavioral changes
Cognitive engagement
5. Integration With Existing Therapies
Leucovorin works best when paired with:
qEEG-guided TMS / MeRT
Speech therapy
Behavioral therapy
Nutritional support
Supplements when appropriate
Who May Be a Good Candidate for Leucovorin?
Leucovorin may be beneficial for individuals with:
Delayed speech or regression in language
Limited verbal communication
Attention and focus challenges
High irritability
Low muscle tone or coordination issues
Developmental delays
Known mitochondrial concerns
Positive FRAA tests (if performed)
Not every patient requires folinic acid—but for those who do, the impact can be meaningful.
Is Leucovorin Safe?
Leucovorin is generally well tolerated.
Potential mild side effects may include:
Hyperactivity during the first week
Sleep changes
Gastrointestinal discomfort (rare)
Our medical provider monitors response closely and adjusts dosing as needed.
Why We Added Leucovorin at Reign-Bow
Because parents deserve every scientifically credible option for their child.
Because early research shows promise.
Because many children with autism have underlying metabolic challenges that traditional therapies don’t address.
And because our clinic is committed to exploring safe, evidence-based enhancements to improve:
Language development
Cognitive processing
Mood regulation
Social communication
Overall quality of life
This addition aligns with our mission:
personalized brain-based care, backed by science and delivered with compassion.
Interested in Learning More? Schedule a Consultation
Leucovorin is now available as an optional therapy for qualified Reign-Bow patients.
Families can request:
A medical review
qEEG-guided treatment planning
Leucovorin eligibility evaluation
📍 Reign-Bow Brain Treatment Center – Lombard, IL
📞 Call: 630-448-2721
💻 www.reignbowtreatmentcenter.com
#pro-gallery-ma5853371-not-scoped .gallery-item-container { opacity: 0 }
#pro-gallery-ma5853371-not-scoped .gallery-item-hover::before { background: transparent !important}A deeper look at autism and what families ask us about leucovorin: a promising new therapy now offered at reign-bow brain treatment center
Families across Lombard, Naperville, Oak Brook, Wheaton, Hinsdale, Elmhurst, Glen Ellyn, Downers Grove, and Oak Park come to Reign-Bow Brain Treatment Center because they want a clearer answer to a hard question: why is my child (or why am I) struggling, and what can actually change it? The article above gives the short answer. This section gives the longer one — the clinical context, the questions parents most often ask in our intake calls, and how a personalized, brain-based plan is built around what the qEEG reveals about autism.
Why a brain-first approach matters for autism
Behavior is the surface; the brain is the system underneath. Two people with the same diagnosis can have very different sensory profiles, sleep architecture, attention systems, and emotional regulation circuits. Programs built on a diagnosis alone treat the average patient — not the person in front of you. A quantitative EEG (qEEG) records electrical activity across 19 scalp sensors and compares each region to age-matched normative data. The result is a map of where networks are over-active, under-active, or out of sync. That map is the foundation our clinicians use to design every plan for autism.
What the qEEG actually reveals about autism
In autism, qEEG findings frequently point to patterns in delta and theta slowing, elevated frontal high-beta linked to anxiety and overload, alpha asymmetry tied to mood, and reduced coherence in the networks that govern executive function and social cognition. These findings do not diagnose autism on their own — diagnoses come from full clinical evaluation. They do give the clinical team specific neurological targets to address with personalized TMS protocols, neurofeedback, and structured parent coaching. That is why we never start treatment without a brain map.
How personalized TMS differs from standard TMS
Standard TMS uses fixed coordinates derived from the average brain. Personalized TMS uses your qEEG and structural landmarks to target the specific region of your network that is out of balance — the frequency, the duration, and the protocol are all built from your data. For families exploring personalized brain-stimulation programs, this is the single biggest reason outcomes vary so widely between clinics. A protocol matched to the brain map will almost always outperform a generic one.
What a typical evaluation and treatment week looks like
New families typically begin with a brief intake call, a qEEG evaluation, and a personalized plan review with our clinical team. When TMS is indicated, a standard course runs roughly five sessions per week for four to six weeks. Each session lasts 20–40 minutes with no sedation, no needles, and no recovery time. Progress is tracked with weekly clinician check-ins, validated parent-report scales, and a repeat qEEG at the end of the course so families can see — not guess — what changed in the brain.
How qEEG-guided care fits with the supports you already have
Brain-based care does not replace ABA, speech, occupational therapy, school IEPs, or your existing medical team. It gives every member of that team a shared map of the underlying neurology, so the speech therapist, the OT, the BCBA, the school psychologist, and the parents can coordinate around the same picture instead of working in isolation. Families consistently tell us that this coordination — more than any single intervention — is what unlocks the first visible gains in the first three to six months.
Frequently asked questions during intake
Parents in our area most often ask: Will my child need medication forever? Why does sleep fall apart during transitions? Why does homework take three hours? Why do meltdowns escalate after school? What does insurance cover? These questions all map to specific regulatory systems in the brain. The Reign-Bow team answers every one of them in plain language, with reference to your child's actual qEEG findings — never with generic talking points.
Where to read more on Reign-Bow
Continue exploring related topics: autism brain mapping, autism treatment program, qEEG for autism, TMS for autism, autism sleep challenges, autism emotional regulation, autism executive function, MeRT alternative, and our full clinical blog. To start the process, visit our contact page or verify your insurance.
How this fits into Reign-Bow's brain-based care model
At Reign-Bow Brain Treatment Center, every plan starts with a qEEG brain map — a non-invasive recording of brainwave activity compared to age-matched normative databases. That map is what allows our clinicians to design personalized brain-stimulation protocols instead of one-size-fits-all care. Families across Lombard, Naperville, Oak Brook, Wheaton, Hinsdale, Elmhurst, Glen Ellyn, and Downers Grove choose this approach because it converts vague symptoms into specific neurological targets.
For families exploring autism brain mapping, our autism treatment program integrates qEEG findings with individualized TMS therapy protocols and parent coaching. Patients seeking care for depression, anxiety, ADHD, PTSD, or TBI follow the same brain-first pathway.
Every article on this site is reviewed by the Reign-Bow clinical team — licensed clinicians, qEEG technologists, and TMS specialists with direct experience treating children, teens, and adults. We update our content as new research, FDA clearances, and clinical guidelines emerge. For care questions, please contact our Lombard office or verify your insurance.
Medical references & further reading
- National Institute of Mental Health — Autism Spectrum Disorder
- NIMH — Brain Stimulation Therapies (TMS overview)
- American Academy of Pediatrics
- U.S. FDA — Transcranial Magnetic Stimulation
- NINDS — Autism Spectrum Disorder
- PubMed — qEEG and autism research
Educational content only. Not a substitute for individualized medical evaluation. Always consult a qualified clinician.
Frequently asked questions
- What does this article cover about Leucovorin: A Promising New Therapy Now Offered at Reign-Bow Brain Treatment Center?
- This article from the Reign-Bow Brain Treatment Center clinical team explains how research & education relates to brain function, what families in Lombard and the Chicago area should know, and how qEEG brain mapping can guide personalized treatment.
- What is qEEG brain mapping?
- Quantitative EEG (qEEG) is a non-invasive recording of brainwave activity that is compared to age-matched normative databases. It is used to identify patterns linked to attention, emotional regulation, sleep, sensory processing, and behavior — and to guide individualized care plans.
- Is TMS therapy safe for children, teens, and adults?
- Transcranial Magnetic Stimulation (TMS) is FDA-cleared for depression and is widely used in personalized brain-stimulation protocols. It is non-invasive, drug-free, and well-tolerated. Each patient at Reign-Bow is evaluated individually before any treatment begins.
- Do you treat patients outside of Lombard?
- Yes. Reign-Bow Brain Treatment Center serves families across DuPage County and the western Chicago suburbs, including Naperville, Oak Brook, Wheaton, Hinsdale, Elmhurst, Glen Ellyn, Downers Grove, and Oak Park.
- Does insurance cover qEEG or TMS therapy?
- Coverage varies by plan and indication. Our team verifies benefits in advance and walks families through every cost option. Use our insurance verification page to start the process.
- How do I schedule a consultation?
- Visit the contact page or call our Lombard office. New families typically start with a brief intake call, a qEEG evaluation, and a personalized brain-based treatment plan.
Originally published on the Reign-Bow Treatment Center blog.
View original